Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN48342048
ISRCTN48342048
Completed
Not Applicable

Hormonal and metabolic effects of diet and exercise programs in obese women with polycystic ovary syndrome : a prospective randomised controlled trial

Karolinska Institute (Sweden)0 sites45 target enrollmentJune 1, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPolycystic ovary syndrome (PCOS)Nutritional, Metabolic, EndocrinePolycystic ovarian syndrome

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Polycystic ovary syndrome (PCOS)
Sponsor
Karolinska Institute (Sweden)
Enrollment
45
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2011
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Karolinska Institute (Sweden)

Eligibility Criteria

Inclusion Criteria

  • •Women aged 18\-40 years diagnosed with PCOS and having body mass index (BMI) \> 27

Exclusion Criteria

  • •1\. The presence of other disease or a different endocrine disorder
  • •2\. An eating disorder
  • •3\. Smoking
  • •4\. Continuous medication including insulin sensitising drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Hormonal and metabolic effects of diet and physical activity in women with polycystic ovary syndrome (PCOS)Polycystic ovary syndrome (PCOS)Pregnancy and Childbirth
ISRCTN18400086Karolinska Institutet50
Completed
Not Applicable
se of insulin sensitisers to revert metabolic syndrome
ISRCTN58810841Hospital Sant Joan de Deu (Spain)52
Active, not recruiting
Phase 1
Diet, physical exercise, and metabolic control intervention to reduce the incidence of major neurocognitive disorders among individuals with type 2 diabetes combined with mild neurocognitive impairment – a pilot studyType 2 diabetesTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2019-003772-39-SEmeå University80
Completed
Not Applicable
Aerobic Exercise With Diet Induces Hormonal, Metabolic, and Psychological ChangesElderlyHormonesInsulin ResistanceDepression
NCT05136742Cairo University60
Active, not recruiting
Not Applicable
Effects on Endocrine-Metabolic Parameters and Body Composition of the Addition of Low-Dose Pioglitazone to Flutamide-Metformin Therapy in Young Women with Hyperinsulinemic Ovarian Hyperandrogenism and Cardiovascular Risk - Pioglitazone in PCOSPolycystic Ovary Syndrome includes anovulatory hyperandrogenism, hyperinsulinemia and/or dyslipidemia. Adiponectin and interleukin-6 are adipocytokines that have been related to abdominal fat excess and/or impaired insulin sensitivity. These cytokines -together with other indices of low-grade inflammation-, sucj as C-reactive protein (CRP), and the neutrophil count, contribute to link insulin-resistant states with cardiovascular disease risks.
EUCTR2005-004163-39-ESHospital Sant Joan de Déu40